Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Duvoux

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Presse Medicale (Paris, France : 1983)|December 2, 1992
[Liver transplantation associated with combined adjuvant treatment in hepatocellular carcinoma. Feasibility and preliminary results]D Cherqui, P Piedbois, C Duvoux, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases]D Cherqui, C Duvoux, F Charlotte, et al.
Transplantation|March 30, 2002
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)G Levy, P Burra, A Cavallari, et al.
Transplantation|September 15, 1995
Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfectionC Duvoux, J M Pawlotsky, D Cherqui, et al.
Journal of Viral Hepatitis|February 7, 2018
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunitiesP A Cortesi, L S Belli, R Facchetti, et al.
Cancer|June 1, 1994
Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot studyD Cherqui, P Piedbois, J Y Pierga, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Immunological disorders in C virus chronic active hepatitis: a prospective case-control studyJ M Pawlotsky, M Ben Yahia, C Andre, et al.
Journal of Hepatology|December 22, 1999
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesionsC Hézode, C Cazeneuve, O Coué, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 7, 2011
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized studyK Boudjema, C Camus, F Saliba, et al.
Journal De Radiologie|August 9, 2011
[Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen]W Ouedraogo, J Tran-Van Nhieu, L Baranes, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Presse Medicale (Paris, France : 1983)|December 2, 1992
[Liver transplantation associated with combined adjuvant treatment in hepatocellular carcinoma. Feasibility and preliminary results]D Cherqui, P Piedbois, C Duvoux, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1994
[Value of a powerful initial immunosuppression after liver transplantation. Prospective study of 60 cases]D Cherqui, C Duvoux, F Charlotte, et al.
Transplantation|March 30, 2002
Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2-hr post-dose levels (C2)G Levy, P Burra, A Cavallari, et al.
Transplantation|September 15, 1995
Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation. A useful test for diagnosis of hepatitis C virus reinfectionC Duvoux, J M Pawlotsky, D Cherqui, et al.
Journal of Viral Hepatitis|February 7, 2018
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunitiesP A Cortesi, L S Belli, R Facchetti, et al.
Cancer|June 1, 1994
Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot studyD Cherqui, P Piedbois, J Y Pierga, et al.
Hepatology (Baltimore, Md.)|April 1, 1994
Immunological disorders in C virus chronic active hepatitis: a prospective case-control studyJ M Pawlotsky, M Ben Yahia, C Andre, et al.
Journal of Hepatology|December 22, 1999
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesionsC Hézode, C Cazeneuve, O Coué, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 7, 2011
Reduced-dose tacrolimus with mycophenolate mofetil vs. standard-dose tacrolimus in liver transplantation: a randomized studyK Boudjema, C Camus, F Saliba, et al.
Journal De Radiologie|August 9, 2011
[Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen]W Ouedraogo, J Tran-Van Nhieu, L Baranes, et al.
Pageof 7